Clinical characteristics, sex differences, and outcomes in patients with normal or near‐normal coronary arteries, non‐obstructive or obstructive coronary artery disease
ML Ouellette, AI Löffler, GA Beller… - Journal of the …, 2018 - Am Heart Assoc
ML Ouellette, AI Löffler, GA Beller, VK Workman, E Holland, JM Bourque
Journal of the American Heart Association, 2018•Am Heart AssocBackground Normal or near‐normal coronary arteries (NNCAs) or nonobstructive coronary
artery disease (CAD) are found on invasive coronary angiography in≈ 55% of patients.
Some attribute this to frequent referral of low‐risk patients. We sought to identify the referral
indications, pretest risk, key clinical characteristics, sex, and outcomes in patients with
NNCAs and nonobstructive CAD versus obstructive CAD on nonemergent invasive coronary
angiography. Methods and Results Over 24 months, 925 consecutive patients were …
artery disease (CAD) are found on invasive coronary angiography in≈ 55% of patients.
Some attribute this to frequent referral of low‐risk patients. We sought to identify the referral
indications, pretest risk, key clinical characteristics, sex, and outcomes in patients with
NNCAs and nonobstructive CAD versus obstructive CAD on nonemergent invasive coronary
angiography. Methods and Results Over 24 months, 925 consecutive patients were …
Background
Normal or near‐normal coronary arteries (NNCAs) or nonobstructive coronary artery disease (CAD) are found on invasive coronary angiography in ≈55% of patients. Some attribute this to frequent referral of low‐risk patients. We sought to identify the referral indications, pretest risk, key clinical characteristics, sex, and outcomes in patients with NNCAs and nonobstructive CAD versus obstructive CAD on nonemergent invasive coronary angiography.
Methods and Results
Over 24 months, 925 consecutive patients were classified as having NNCAs (≤20% stenosis), nonobstructive CAD (21–49% stenosis), or obstructive CAD (≥50% stenosis). Outcomes included cardiac death, nonfatal myocardial infarction, and late revasclarization. NNCAs were found in 285 patients (31.0%), nonobstructive CAD in 125 (13.5%), and obstructive CAD in 513 (55.5%). NNCAs or nonobstructive CAD was found in 40.5% with stress ischemia, 27.9% after a non‐ST‐elevation myocardial infarction, and in 55.5% with stable or unstable angina. More women than men (53.5% versus 37.2%; P<0.001) had NNCAs or nonobstructive CAD across all referral indications. Pretest risk was high and ICA appropriate in 75.5% and 99.2% of patients, respectively. Annual rates of cardiac death or nonfatal myocardial infarction were 1.0%, 1.1%, and 6.7%, respectively, for patients with NNCAs, nonobstructive CAD, and obstructive CAD (P<0.001). No sex differences in outcomes were observed with either NNCAs, nonobstructive CAD, or obstructive CAD (P=0.84).
Conclusions
Many (44.5%) patients undergoing nonemergent invasive coronary angiography have NNCAs or nonobstructive CAD despite high pretest risk, including ischemia and troponin elevation. Although women had more NNCAs or nonobstructive CAD, there were no differences in event rates by sex. Patients with NNCAs and nonobstructive CAD had very low event rates.
Am Heart Assoc